Metidate XL 36 mg Prolonged-Release Tablets
- Licence status
- Withdrawn: 29/08/2019
- Active substances
- Methylphenidate hydrochloride, Methylphenidate hydrochloride
- Dosage Form
- Prolonged-release tablet
- Licence number
- PA0711/200/002
- Licence holder
- Rowex Ltd
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- N06BA Centrally acting sympathomimetics, N06BA04 methylphenidate
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 13/04/2012